Søgeresultater - Lars Bauer

Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson’s Disease: A Analysis af Nir Giladi, Mahnaz Asgharnejad, Lars Bauer, Frank Grieger, Babak Boroojerdi

Få fuldtekst

Efficacy of Rotigotine at Different Stages of Parkinson’s Disease Symptom Severity and Disability: A Analysis According to Baseline Hoehn and Yahr Stage af Nir Giladi, Anthony P. Nicholas, Mahnaz Asgharnejad, Elisabeth Dohin, Franz Woltering, Lars Bauer, Werner Poewe

Få fuldtekst

Comparison of established and preliminarily proposed ASAS MRI working group cut-offs for inflammatory MRI lesions in the sacroiliac joints in radiographic and non-radiographic axia... af Xenofon Baraliakos, Martin Rudwaleit, Pedro M Machado, Bengt Hoepken, Lars Bauer, Rachel Tham, Thomas Kumke, Mindy Kim

Få fuldtekst

Maintained improvement in patient-reported outcomes in early axial spondyloarthritis following certolizumab pegol dose reduction: findings from the randomised period of a phase 3b... af Antoni Chan, Jon Wood, Lachrissa Burns, Thomas Kumke, Bengt Hoepken, Mindy Kim, Lars Bauer, Kirsten Mackay, Karl Gaffney

Få fuldtekst

Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP status af Atul Deodhar, Martin Rudwaleit, Bengt Hoepken, Lars Bauer, Lianne Gensler, Walter Maksymowych, Thomas Kumke, Mindy Kim, Simone Emanuele Auteri

Få fuldtekst

A Randomized Study of Rotigotine Dose Response on ‘Off’ Time in Advanced Parkinson's Disease af Anthony P. Nicholas, Rupam Borgohain, Pedro Chaná, Erwin Surmann, Emily L. Thompson, Lars Bauer, John Whitesides, Lawrence W. Elmer

Få fuldtekst

Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial... af Filip van den Bosch, Martin Rudwaleit, Helena Marzo-Ortega, Natasha de Peyrecave, Victoria Navarro-Compán, Lars Bauer, Rachel Tham, Thomas Kumke, Mindy Kim

Få fuldtekst

Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISE af Robert Landewé, Désirée van der Heijde, Maxime Dougados, Xenofon Baraliakos, Filip Van den Bosch, Karl Gaffney, Lars Bauer, Bengt Hoepken, Natasha de Peyrecave, Karen Thomas, Lianne S. Gensler

Få fuldtekst

The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW af Martin Rudwaleit, James T Rosenbaum, Irene van der Horst-Bruinsma, Maria Misterska-Skora, Rianne van Bentum, Frank D Verbraak, Thomas Rath, Bengt Hoepken, Oscar Irvin-Sellers, Brenda VanLunen, Lars Bauer

Få fuldtekst